When Axin, a negative regulator of the Wnt signaling pathway, was expressed in COS cells, it coeluted with glycogen synthase kinase-3b (GSK-3b), b-catenin, and adenomatous polyposis coli protein (APC) in a high molecular weight fraction on gel ®ltration column chromatography. In this fraction, GSK-3b, b-catenin, and APC were co-precipitated with Axin. Although bcatenin was detected in the high molecular weight fraction in L cells on gel ®ltration column chromatography, addition of conditioned medium expressing Wnt3a to the cells increased b-catenin in the low molecular weight fraction. However, Wnt-3a-dependent accumulation of b-catenin was greatly inhibited in L cells stably expressing Axin. Axin also suppressed Wnt-3a-dependent activation of Tcf-4 which binds to b-catenin and acts as a transcription factor. These results suggest that Axin forms a complex with GSK-3b, b-catenin, and APC, resulting in the stimulation of the degradation of bcatenin and that Wnt-3a induces the dissociation of bcatenin from the Axin complex and accumulates bcatenin.
Introduction
Axin, which is a product of the mouse Fused locus, has been identi®ed as a negative regulator of the Wnt signaling pathway (Zeng et al., 1997) . Fused is a mutation that causes dominant skeletal and neurological defects and recessive lethal embryonic defects including neuroectodermal abnormalities (Reed, 1937 
, and a transgenic insertional allele, Fu Tgl , carry axis duplications and are lethal between days 8 and 10 of gestation, suggesting that the Fused locus plays a role in the determination of the embryonic axis (Gluecksohn-Schoenheimer, 1949; Jacobs-Cohen et al., 1984; Perry et al., 1995) . The cDNA of this locus has been sequenced, and the Fused gene has been renamed Axin. Injection of wild-type Axin into Xenopus embryos blocks axis formation and coinjection of Axin inhibits Wnt-8-, dishevelled (Dsh)-, and kinase negative glycogen synthase kinase-3b (GSK-3b)-induced axis duplication (Zeng et al., 1997) . These results suggest that Axin exerts its effects on axis formation by inhibiting the Wnt signaling pathway.
We have identi®ed rat Axin (rAxin) and its homolog, Axil (for Axin like), as GSK-3b-interacting proteins Yamamoto et al., 1998) . Axil has 44% amino acid identity with rAxin and inhibits Xwnt-8-induced axis formation of Xenopus embryos like Axin . Both rAxin and Axil bind to not only GSK-3b but also bcatenin directly and promote GSK-3b-dependent phosphorylation of b-catenin Yamamoto et al., 1998) . Furthermore, the regulators of G protein signaling (RGS) domain of rAxin interacts directly with adenomatous polyposis coli protein (APC) and transfection of rAxin in COS cells stimulates the degradation of b-catenin . Consistent with our observations, other groups have also reported that Axin forms a complex with GSK-3b, b-catenin, and APC (Hart et al., 1998; Itoh et al., 1998; Sakanaka et al., 1998) . Conductin, an Axin homolog, has been also shown to interact with GSK3b, b-catenin, and APC and to stimulate the degradation of b-catenin (Behrens et al., 1998) . Mouse conductin has 97% amino acid identity with rat Axil, indicating that conductin is Axil. Since it has been shown that b-catenin is ubiquitinated and that mutations of the phosphorylation site for GSK-3b in b-catenin inhibit its ubiquitination and result in the stabilization of the protein (Miller and Moon, 1996; Yost et al., 1996; Aberle et al., 1997) , Axin and Axil (conductin) could regulate the stabilization of b-catenin by forming a complex with GSK-3b, b-catenin and APC.
The Wnt and Wg signaling pathways are essential for developmental decisions, regulating anterior-posterior and dorsal-ventral patterns in both vertebrates and ies (Nusse and Varmus, 1992; Miller and Moon, 1996; Cadigan and Nusse, 1997) . In vertebrates, the Wnt signaling pathway consists of an intracellular cascade that includes frizzled, Dsh, GSK-3b, b-catenin, and lymphocyte enhancer binding factor/T cell factor (Lef/ Tcf). In the absence of Wnt, GSK-3b is active and antagonizes downstream elements of the Wnt signaling pathway through changes in the b-catenin level (He et al., 1995; Pierce and Kimelman, 1995) . In the presence of Wnt, GSK-3b is inactivated through Dsh, there is a decrease in the phosphorylation of b-catenin and an increase in its stability, and b-catenin translocates to the nucleus (Yost et al., 1996) . This translocation involves the association of b-catenin with the transcriptional enhancers of Lef/Tcf family (Behrens et al., 1996; Molenaar et al., 1996) . Thus, Wnt induces the accumulation of b-catenin and transmits the signal to nucleus. However, how Wnt stabilizes b-catenin and how Axin aects Wnt-induced accumulation of bcatenin are not known.
Although Wnt proteins are secretory, they predominantly bind to the cell surface or extracellular matrix (Papko et al., 1987; Smolich et al., 1993) . Since puri®ed Wnt proteins have not been available for signal transduction studies, a generalized model of Wnt/Wg signaling described above has been inferred from genetic analysis in Drosophila and ectopic expression of Wnt in mammalian cells or Xenopus embryos. Small amounts of biologically active Wnt-1 or Wg can be found in culture medium conditioned by cells expressing these proteins (van Leeuwen et al., 1994; Bradley and Brown, 1995) . The Wg-conditioned medium from Schneider cells increases the levels of armadillo protein in Drosophila imaginal disc cells and inactivates GSK-3 in mouse ®broblasts (van Leeuwen et al., 1994; Cook et al., 1996) . The Wnt-1 protein in conditioned medium induces morphological transformation and stimulates DNA synthesis of epithelial cells (Bradley and Brown, 1995) . However, analysis of the Wnt signaling pathway using the soluble mammalian Wnt protein has not yet been done. Wnt-1 and Wnt-3a are expressed in largely overlapping regions within the dorsal central nervous system (Parr et al., 1993) . Null mutants of Wnt-1 and Wnt-3a genes in mouse have shown that Wnt-1 regulates midbrain development (McMahon and Bradley, 1990; Thomas and Capecchi, 1990) and that Wnt-3a regulates paraxial mesoderm formation (Takada et al., 1994) . However, both Wnt-1 and Wnt-3a can contribute to tumorgenesis (Roelink et al., 1990) , suggesting that Wnt-3a may share the same signaling pathway as Wnt-1. Indeed, compound mutants of both Wnt-1 and Wnt-3a have shown that these two Wnt genes regulate the development of neural crest and CNS redundantly (Ikeya et al., 1997) . Therefore, by the use of conditioned medium expressing Wnt-3a, we examined the eect of Axin on Wnt signaling pathway in mammalian cells. Here we show that Axin co-elutes with APC, b-catenin, and GSK-3b on gel ®ltration column chromatography, that Wnt-3a induces the accumulation of b-catenin which dissociates from this complex, and that Axin inhibits Wnt-3a-induced accumulation of b-catenin and activation of Tcf-4.
Results
Elution pro®les of rAxin, APC, b-catenin, and GSK-3b in COS cells on gel ®ltration column chromatography
We have recently found that rAxin has dierent binding sites for APC, b-catenin, and GSK-3b Kishida et al., 1998) . To examine the rAxin-containing complex further, we used Superdex 200 gel ®ltration to separate the protein complex in wild-type COS cells and the cells expressing MycrAxin. Cell extracts were fractionated, and Myc-rAxin, APC, b-catenin, and GSK-3b in each fraction were probed with their speci®c antibodies (Figure 1a) . In wild-type COS cells, APC eluted with a peak at fractions 17/18. b-catenin eluted as a single broad protein population with a peak at fractions 19/20. GSK-3b appeared as a single protein population with a peak at fractions 30/31. When Myc-rAxin was expressed in COS cells, it eluted as one minor and one major peaks at fractions 17/18 and 23/24, respectively ( Figure 1a ). Elution pro®les of APC and b-catenin did not change signi®cantly in COS cells expressing Myc-rAxin, whereas that of GSK-3b changed markedly (Figure 1a) . A peak of GSK-3b was detected at fractions 23/24 which is consistent with the second peak of Myc-rAxin. Furthermore, GSK-3b was also detected at fractions 17/18 in which APC, bcatenin, and the ®rst peak of Myc-rAxin eluted. These results suggest that Axin forms distinct complexes depending on its binding partners. To con®rm this possibility, Myc-rAxin was immunoprecipitated with the anti-Myc antibody (Figure 1b ). Myc-rAxin in fractions 17/18 was co-precipitated with APC, bcatenin, and GSK-3b, whereas Myc-rAxin in fractions 23/24 was co-precipitated with GSK-3b. These results indicate that in COS cells, rAxin forms at least two types of complexes of which one contains APC, bcatenin, and GSK-3b and the other GSK-3b.
Eect of rAxin on Wnt-3a-induced accumulation of b-catenin
Stable expression of several Wnt genes, including Wnt-1 and Wnt-3a, stabilizes b-catenin in mammalian cells (Hinck et al., 1994; Papko et al., 1996; Shimizu et al., 1997) . We also observed soluble Wnt-3a proteins secreted into the culture medium have the same action on b-catenin (Shibamoto et al., 1999) . To examine the eect of rAxin on the action of Wnt-3a, we (7) expression of Myc-rAxin were subjected to gel ®ltration column chromatography. An aliquot of each fraction was probed with the anti-Myc, anti-APC, anti-b-catenin, and anti-GSK-3b antibodies. (b) Complex formation of rAxin with APC, b-catenin, and GSK-3b. An aliquot of the fractionated lysates from COS cells expressing Myc-rAxin was immunoprecipitated with the anti-Myc antibody. The immunoprecipitates were probed with the antibodies described in a. The protein markers used were thyroglobulin (M r =669 000), ferritin (M r =440 000), and aldolase (M r =158 000). IP, immunoprecipitation; Ig, immunoglobulin. The results shown are representative of three independent experiments established cell lines stably expressing rAxin. In this experiment mouse ®broblast L cells were used, because the changes in the expression levels of b-catenin by Wnt are easily observed due to little expression of cadherin in the cells (Nagafuchi et al., 1987) . While Wnt-3a-conditioned medium induced the accumulation of b-catenin in time-and dose-dependent manners in wild type L cells, Wnt-3a-dependent increase of bcatenin was greatly inhibited in L cells expressing rAxin (Figure 2) . It has been shown that b-catenin interacts with Lef/Tcf transcription factor (Behrens et al., 1996; Molenaar et al., 1996) and that overexpression of Wnt-1 activates Lef/Tcf (Korinek et al., 1998) . To determine whether Axin aects Wnt-3a-dependent gene expression through Lef/Tcf, we used a luciferase reporter plasmid containing a Lef/Tcf binding site upstream of c-fos promoter (pTOP-FLASH). Wnt-3a stimulated luciferase expression in wild-type L cells when the cells were transfected with pcDNAI/hTcf-4 and pTOPFLASH (Figure 3) . However, Wnt-3a did not stimulate luciferase expression in L cells expressing rAxin (Figure 3 ). DNhTcf-4 is a deletion mutant which does not bind to b-catenin (Behrens et al., 1996; Molenaar et al., 1996; . Wnt-3a-dependent luciferase activity was not observed in the cells transfected with pcDNAI/ DNhTcf-4 (Figure 3) . Thus, Axin prevents Wnt-3a-induced accumulation of b-catenin and inhibits the gene expression through Tcf-4.
It has been demonstrated that b-catenin accumulates in SW480 human colorectal cancer cells of which APC is truncated and in AtT20 mouse pituitary and C57MG mouse mammary epithelial cells expressing Wnt-1 and that the low molecular weight complexed b-catenin on gel ®ltration column chromatography increases in these cells (Munemitsu et al., 1995; Papko et al., 1996) . When the extracts of wild-type L cells were applied to a gel ®ltration column, most of the b-catenin eluted with a peak at fractions 17/18 (high molecular weight complex), while a small amount of b-catenin eluted with a peak at fraction 26/27 (low molecular weight complex) (Figure 4) . Addition of Wnt-3a-conditioned medium to L cells increased the levels of b-catenin greatly in the low molecular weight complex (Figure 4) . However, the accumulation of b-catenin induced by Wnt-3a was not observed in L cells stably expressing 3 and 4) , the cells were treated with Wnt-3a-conditioned medium (lanes 2, 4, 6 and 8) or control medium (lanes 1, 3, 5 and 7). The luciferase activity was assayed and expressed as the fold increase as compared with the levels observed in the cells expressing pcDNAI/hTcf-4 and pTOP-FLASH treated with control medium. The results shown are the mean+s.e. of four independent experiments rAxin ( Figure 4) . Furthermore, expression of rAxin resulted in a reduction in the high molecular weight complexed b-catenin (Figure 4) . It has been shown that expression of APC inhibits the accumulation of bcatenin induced by expression of Wnt-1 in both the high and low molecular weight complexes (Papko et al., 1996) and abrogates the transcription activity of hTcf-4 Morin et al., 1997) . Therefore, the mode of action of Axin in the degradation of b-catenin may be similar to that of APC.
Degradation of b-catenin by rAxin
We have demonstrated that the RGS domain of rAxin interacts directly with APC and that rAxin stimulates the degradation of b-catenin in COS cells . Therefore, we examined whether rAxin substitutes for APC in the downregulation of bcatenin and which domain of rAxin is important for its activity. b-catenin was strongly stained in cytoplasm and nuclei of SW480 cells (Figure 5b, d, f, and h) . Microinjection of rAxin (full length) into SW480 cells reduced b-catenin markedly (Figure 5a and b) . The expressed rAxin was homogeneously stained in the cytoplasm in some cells and observed as small particles in others. We do not know the signi®cance of this dierence at present. rAxin-(298 ± 832) in which the RGS domain is deleted also showed the same activity as full-length rAxin (Figure 5c and d) . These results indicate that rAxin substitutes for APC and that the interaction of APC with rAxin through the RGS domain is not essential for the degradation of bcatenin, and are consistent with the recent observations using human Axin (Hart et al., 1998) . Although rAxin has a Dsh homologous domain in the C-terminal region, the function of this domain is not known (Zeng et al., 1997; Ikeda et al., 1998) . rAxin-(1 ± 713) in which the Dsh homologous domain is removed did not aect the levels of b-catenin (Figure 5e and f). Although rAxin-(298 ± 506) binds to both GSK-3b and b-catenin directly and enhances the phosphorylation of b-catenin by GSK-3b , it did not reduce the (Figure 5g and h) . These results suggest that the Dsh domain of rAxin is necessary for its degradation activity and that the phosphorylation of b-catenin is not sucient for its degradation. Since the expression of b-catenin in L cells was very low as compared with SW480 cells, the reduction of the levels of b-catenin was not signi®cantly observed by microinjection of rAxin (full length) and rAxin-(298 ± 832) into L cells (data not shown). However, rAxin-(1 ± 229), rAxin-(298 ± 506), and rAxin-(713 ± 832) accumulated cytoplasmic bcatenin (data not shown). It appears that these rAxin fragments act through a dominant-negative mechanism to inhibit an endogenous Axin activity.
Discussion
We have demonstrated here that Axin appears as two peaks on gel ®ltration column chromatography. Axin forms a complex with GSK-3b, b-catenin, and APC in the high molecular weight fractions, whereas it also complexes with GSK-3b in the low molecular weight fraction. It has been shown that the distribution of bcatenin on gel ®ltration column chromatography varies depending on cell types (Munemitsu et al., 1995; Papko et al., 1996; Stewart and Nelson, 1997) . In epithelial cells such as MDCK cells, almost all the bcatenin co-fractionates and co-immunoprecipitates with APC and cadherin in the high molecular weight fraction. However, in colorectal cancer cells such as SW480 cells, b-catenin appears in the high and the low molecular weight fractions and a b-catenin/Lef-1 complex is detected (Por®ri et al., 1997) . These results suggest that b-catenin distributes between the high and low molecular weight fractions depending on binding partners. It is notable that Axin and b-catenin are detected in dierent fractions in the low molecular weight fraction and are not associated with each other. EGF receptor, fascin, and ZO-1 have been also found to interact with b-catenin (Hoschuetzky et al., 1994; Rajasekaran et al., 1996; Tao et al., 1996) . The relationship between these b-catenin binding partners and Axin remains to be clari®ed.
A long-standing diculty in studying the action of mammalian Wnt genes has been the inability to isolate their products in the soluble form that demonstrates functional activity. It has been shown that a secreted form of Wg increases the levels of armadillo protein in Drosophila imaginal disc cells (van Leeuwen et al., 1994) . In the present study, we have shown for the ®rst time that Wnt-3a-conditioned medium induces the activation of Tcf-4 in L cells in addition to the accumulation of b-catenin. Our results indicate that Wnt-3a protein can act on target cells externally as a soluble secreted factor through the same signaling pathway as Wg in Drosophila. This system will be helpful for studies to clarify the Wnt signaling pathway in mammalian cells. Our results have also demonstrated that Wnt-3a-conditioned medium induces the accumulation of b-catenin in the low molecular weight fraction. Furthermore, expression of Axin decreases the levels of b-catenin, primarily from the low molecular weight fraction, but decreases in the high molecular weight fraction are also detected. This action of Axin is similar to that of APC in C57MG cells overexpressing Wnt-1 and in SW480 cells (Munemitsu et al., 1995; Papko et al., 1996) . These results suggest that a balance between the high and low molecular weight complexes containing b-catenin is closely regulated and that Axin and APC play a role in limiting the accumulation of b-catenin in the low molecular weight complex. Although the mechanism by which Wnt accumulates b-catenin in the low molecular weight complex is not known, Wnt may regulate the assembly of the complex consisting of Axin, APC, b-catenin, and GSK-3b and induce the dissociation of b-catenin from the complex, so that b-catenin can bind to dierent partners such as Lef/Tcf and transmit signals.
The degradation of b-catenin by the ubiquitinproteasome pathway could represent a mechanism by which the turnover of b-catenin is regulated (Aberle et al., 1997) . Although the role of APC in the degradation of b-catenin has not been understood, APC could be involved in the ubiquitination of b-catenin. It is theoretically possible that Axin functions downstream of or in parallel with APC because expression of Axin stimulates the degradation of b-catenin in SW480 cells. It has been shown that APC forms a complex with and is phosphorylated by GSK-3b and that the phosphorylation increases the binding of APC to b-catenin . By analogy with Axin, APC may stimulate the phosphorylation of b-catenin by GSK-3b. APC binds directly to Axin through the RGS domain, whereas the truncated form of APC in SW480 cells does not . It is possible that the role of Axin and APC in the high molecular weight complex might be to bring GSK-3b and b-catenin together and to stimulate the ubiquitination of bcatenin, resulting in its degradation through the proteasome pathway. The results that rAxin-(298 ± 832) downregulates b-catenin like rAxin (full length) indicate that the interaction of Axin with APC is not required for the degradation of b-catenin. However, rAxin-(1 ± 229) stabilizes b-catenin in L cells. Furthermore, APC fragments binding to conductin (Axil) stabilize b-catenin in Neuro2A cells (Behrens et al., 1998) . These results still suggest that the interaction of APC with Axin or Axil may be necessary for the degradation of b-catenin. Therefore, it is tempting to speculate that APC and Axin have the ability to degrade b-catenin when they are overexpressed individually but that they act cooperatively in the intact cells expressing endogenous levels of these proteins. We have also found that rAxin-(1 ± 713) does not degrade b-catenin in SW480 cells. This result suggests that the C-terminal region of rAxin is necessary for downregulation of b-catenin. Since the C-terminal region of Axin contains the Dsh homologous domain of which function is not known (Zeng et al., 1997; Ikeda et al., 1998) , this domain may be responsible for binding to protein(s) which regulates the degradation of b-catenin.
Materials and methods

Materials and chemicals
L cells, SW480 cells, and pcDNAI/hTcf-4, pcDNAI/ DNhTcf-4, and pTOPFLASH were kindly supplied by Drs A Nagafuchi and S Tsukita (Kyoto Graduate University, Kyoto, Japan), E Tahara (Hiroshima UniInhibition of Wnt-dependent accumulation of b-catenin by Axin M Kishida et al versity, Hiroshima, Japan), and M van de Wetering and H Clevers (University Hospital, Utrecht, The Netherlands), respectively. The anti-Myc antibody was generated from 9E10 cells. pBJ-Myc/rAxin-(298 ± 832), pEF-BOS-Myc/ rAxin-(1 ± 713), pEF-BOS/Myc-rAxin-(298 ± 506), pBJMyc/rAxin-(1 ± 229), and pBJ-Myc/rAxin-(713 ± 832) were constructed as described . To construct pBJ-Myc/rAxin (full length), pBSKS/rAxin was digested with XbaI and EcoRV. The 1.2-kb fragment encoding rAxin-(1 ± 401) and the 1.3-kb fragment encoding rAxin-(402 ± 832) were inserted into pBJ-Myc which was digested with BamHI, blunted with Klenow fragment, and digested with XbaI. The anti-APC (Ab-1), and b-catenin (for immunoblotting) and GSK-3b antibodies were purchased from Calbiochem (La Jolla, CA, USA) and Transduction Laboratories (Lexington, KY, USA), respectively. The anti-b-catenin antibody (for immunohistochemistry), and Cy2-labeled anti-rabbit IgG and Cy3-labeled anti-mouse IgG were from Sigma (St Louis, MO, USA) and Amersham Pharmacia Biotech Inc. (Buckinghamshire, UK), respectively.
Production of Wnt-3a proteins in cultures cells
The detailed procedure to prepare Wnt-3a containing conditioned medium will be described elsewhere (Shibamoto et al., 1999) . Brie¯y, a plasmid vector, pGKWnt-3a, was generated that contained a cDNA fragment, including the entire open reading frame of mouse Wnt-3a, fused to a promoter of rat phosphoglycerate kinase-I gene (PGK promoter) and polyadenylation sequences of bovine growth hormone gene, together with a neomycin phosphotransferase gene (neo) driven by PGK promoter. L cells were transfected with this plasmid by calcium phosphate method and a number of stably transfected clones were established. A stably transfected clone, which secreted soluble Wnt-3a proteins into the medium most eciently, was used to prepare Wnt-3a containing conditioned medium while a L cell clone, which was stably transfected with vector alone, was used to prepare control medium in this study.
Cell culture
COS and L cells were grown in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% calf serum (ICN Biomedicals, Inc., OH, USA) and fetal calf serum, respectively, at 378C. SW480 cells were grown in RPMI1640 supplemented with 10% fetal calf serum. L cells stably expressing Myc-rAxin were produced by transfecting pBJ-Myc/rAxin and pNeo. Colonies of the cells resistant to 400 mg/ml G418 (Geneticin1, GIBCO ± BRL, Life Technologies, Inc., Rockville, MD, USA) were picked up at 14 ± 20 days after transfection. Subsequently, the cells expressing Myc-rAxin among the G418-resistant cells were further selected by immunoblot analysis using the anti-Myc antibody.
When the accumulation of b-catenin in response to Wnt3a was examined in L cells, con¯uent cells (35-mm-diameter dish) were washed with DMEM twice and 0.2 ml of Wnt-3a-conditioned medium which was adjusted to a total volume of 1 ml with DMEM was added to the cells. After stimulation for 3 h, the cells were lysed in 100 ml of lysis buer and the lysates (20 ml) were probed with the anti-bcatenin antibody.
Gel ®ltration chromatography
Two dishes (10-cm diameter) of con¯uent cells were lysed in 0.4 ml of lysis buer (20 mM Tris/HCl at pH 8.0, 137 mM NaCl, 1% Nonidet-P40, 10% glycerol, 1 mM EGTA, 1.5 mM MgCl 2 , 1 mM dithiothreitol (DTT), 50 mM NaF, 1 mM Na 3 VO 4 20 mg/ml aprotinin, 20 mg/ml leupeptin, and 1 mM phenylmethylsulfonyl¯uoride (PMSF)). After the cell extracts were centrifuged, the supernatants were adjusted to a total protein concentration of 3 mg/ml with lysis buer, and 0.3 ml was applied to Superdex 200HR 10/30 column which was equilibrated with equilibration buer (25 mM Tris/HCl at pH 8.0, 250 mM NaCl, 1 mM DTT and 0.1% NP-40) (Munemitsu et al., 1995) . The elution was performed with the same buer at a¯ow rate of 0.5 ml/min. Fractions of 0.5 ml each were collected. An aliquot (20 ml) of each fraction was probed with the anti-Myc, anti-APC, anti-b-catenin, and anti-GSK-3b antibodies. Where speci®ed, an aliquot (200 ml) of each fraction from the extract of COS cells expressing Myc-rAxin was immunoprecipitated with the anti-Myc antibody. The immunoprecipitates were probed with the same antibodies described.
Luciferase assay L cells (35-mm-diameter dish) were transfected with pTOPFLASH, pcDNAI/hTcf-4, and pME18S/lacZ . At 46 h after transfection, the cells were deprived of serum for 6 h, then treated with Wnt-3a (0.2 ml) for 8 h. The cells were lysed and luciferase activity was measured using a PicaGene (Toyo B-NET Co., Ltd., Tokyo, Japan) and lumiphotometer TD4000 (Futaba Medical, Tokyo, Japan). To standardize the transfection eciency, pME18S/lacZ carrying SRa promoter linked to the coding sequence of b-galactosidase gene was used as an internal control.
Microinjection, immuno¯uorescence, and confocal laserscanning microscopy SW480 cells were grown on glass coverslips and microinjected with various plasmids (0.2 ± 0.8 mg/ml) using micromanipulator 51711 and transjector 52461 (Eppendorf-Netheler-Hinz GmbH, Hamburg, Germany). The following procedures were performed at room temperature. At 4 h post-microinjection, the cells were ®xed for 20 min in phosphate buered saline (PBS) containing 4% paraformaldehyde. After washing with PBS three times, the cells were permeabilized with PBS containing 0.1% Triton X-100 and 2 mg/ml bovine serum albumin for 12 h. The cells were washed and incubated for 1 h with the anti-Myc and anti-b-catenin antibodies. After washing with PBS, they were further incubated for 1 h with Cy3-labeled anti-mouse IgG or Cy2-labeled antirabbit IgG. Coverslips were washed with PBS, mounted on glass slides, and viewed with a confocal laser-scanning microscope (TCS-NT1, Leica-laser-technik GmbH, Heidelberg, Germany).
